Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...
CellFE, a leader in non-viral gene editing technology, today announced the launch of its highly anticipated CellFE T-Rest ("Resting T Cell Kit"), a first-in-class cell manufacturing transfection media ...
In the Fall 2024 grant cycle, American Cancer Society invests more than $12 million in new exploratory and translational grants. Last Fall, the American Cancer Society (ACS) released the full list of ...